Get the Stockscreener App
1.80
5.76%
-0.11
After Hours:
1.81
0.01
+0.56%
Caribou Biosciences Inc stock is traded at $1.80, with a volume of 573.43K.
It is down -5.76% in the last 24 hours and up +0.56% over the past month.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
See More
Previous Close:
$1.91
Open:
$1.9
24h Volume:
573.43K
Relative Volume:
0.41
Market Cap:
$167.62M
Revenue:
$34.48M
Net Income/Loss:
$-102.07M
P/E Ratio:
-1.2329
EPS:
-1.46
Net Cash Flow:
$-104.90M
1W Performance:
-3.74%
1M Performance:
+0.56%
6M Performance:
+69.81%
1Y Performance:
-11.33%
1-Day Range:
$1.79
$1.91
1-Week Range:
$1.77
$1.92
52-Week Range:
$0.66
$2.9995
Caribou Biosciences Inc Stock (CRBU) Company Profile
Name
Caribou Biosciences Inc
Sector
Industry
Phone
510-982-6030
Address
2929 7TH STREET, SUITE 105, BERKELEY
Compare CRBU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
1.80 | 165.76M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-08-23 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-31-23 | Initiated | Evercore ISI | Outperform |
| Jul-11-23 | Initiated | Truist | Buy |
| Feb-18-22 | Initiated | RBC Capital Mkts | Outperform |
| Dec-01-21 | Initiated | Oppenheimer | Outperform |
| Nov-30-21 | Initiated | H.C. Wainwright | Buy |
| Nov-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Aug-17-21 | Initiated | BofA Securities | Buy |
| Aug-17-21 | Initiated | Citigroup | Neutral |
| Aug-17-21 | Initiated | SVB Leerink | Outperform |
View All
Caribou Biosciences Inc Stock (CRBU) Latest News
330,831 Shares in Caribou Biosciences, Inc. $CRBU Bought by Nuveen LLC - MarketBeat
Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference - Investing News Network
Caribou Biosciences Inc. Could See a Relief Rally From SupportJuly 2025 Snapshot & Free Weekly Chart Analysis and Trade Guides - beatles.ru
Is Caribou Biosciences Inc. exposed to political riskEarnings Overview Report & Free Fast Entry Momentum Trade Alerts - beatles.ru
Caribou Biosciences Inc. Trading Near Value Zone — Recovery Ahead2025 Analyst Calls & Consistent Profit Focused Trading Strategies - beatles.ru
Can Caribou Biosciences Inc. lead its sector in growthWeekly Market Summary & AI Optimized Trade Strategies - beatles.ru
Citi Sticks to Its Buy Rating for Caribou Biosciences (CRBU) - The Globe and Mail
Citi Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $5 - 富途牛牛
Hedge Fund Moves: Is Caribou Biosciences Inc. stock undervalued right nowRate Hike & Capital Efficiency Focused Strategies - خودرو بانک
Is Caribou Biosciences Inc. stock undervalued right nowJuly 2025 Movers & Consistent Return Strategy Ideas - خودرو بانک
What are Caribou Biosciences Inc.’s growth leversDividend Hike & Free Technical Confirmation Trade Alerts - خودرو بانک
Price momentum metrics for Caribou Biosciences Inc. explainedJuly 2025 Earnings & Reliable Entry Point Alerts - Newser
Caribou Biosciences Inc. stock daily chart insights2025 EndofYear Setup & Verified Chart Pattern Signals - Newser
Can a trend reversal in Caribou Biosciences Inc. lead to recoveryWeekly Gains Summary & Real-Time Volume Spike Alerts - Newser
Understanding Caribou Biosciences Inc.’s price movementWeekly Trade Summary & AI Enhanced Trade Execution Alerts - Newser
Caribou Biosciences Inc. stock prediction for this weekSell Signal & AI Enhanced Trade Execution Alerts - Newser
How does Caribou Biosciences Inc. compare to its peersTrade Performance Summary & Weekly Market Pulse Updates - خودرو بانک
Caribou Biosciences Inc. stock trend outlook and recovery pathRisk Management & Community Consensus Stock Picks - Newser
News impact scoring models applied to Caribou Biosciences Inc.Market Risk Analysis & Growth Oriented Trade Recommendations - Newser
What is Caribou Biosciences Inc.’s book value per shareJuly 2025 Action & Entry Point Confirmation Alerts - خودرو بانک
Backtesting results for Caribou Biosciences Inc. trading strategiesGap Down & Weekly Top Performers Watchlists - Newser
Chart based analysis of Caribou Biosciences Inc. trendsIndex Update & Fast Exit/Entry Strategy Plans - Newser
Caribou Biosciences Inc.’s volatility index tracking explained2025 Institutional Moves & Weekly High Return Stock Forecasts - Newser
Retail Trends: Will Caribou Biosciences Inc. benefit from green energy policiesEarnings Beat & Community Trade Idea Sharing Platform - خودرو بانک
Long term hold vs stop loss in Caribou Biosciences Inc.Treasury Yields & Fast Entry Momentum Trade Alerts - Newser
Using Python tools to backtest Caribou Biosciences Inc. strategiesInsider Buying & Step-by-Step Swing Trade Plans - Newser
Quantitative breakdown of Caribou Biosciences Inc. recent moveMarket Growth Summary & Free High Return Stock Watch Alerts - Newser
What recovery options are there for Caribou Biosciences Inc.Portfolio Return Summary & Long-Term Capital Growth Ideas - Newser
Aug Retail: Will Caribou Biosciences Inc. benefit from green energy policies2025 Buyback Activity & Growth Focused Stock Pick Reports - خودرو بانک
Gene Editing Market to Surpass USD 15.46 Billion by 2032, Fueled by Breakthroughs in CRISPR Technology and Precision Medicine – SNS Insider - GlobeNewswire Inc.
Aug Movers: What are the future prospects of Caribou Biosciences Inc.2025 Analyst Calls & Smart Investment Allocation Tips - خودرو بانک
Historical volatility pattern of Caribou Biosciences Inc. visualizedPortfolio Performance Summary & Step-by-Step Swing Trade Plans - Newser
Chartists Watching For Breakout in Caribou Biosciences Inc.July 2025 Sector Moves & High Return Trade Guides - beatles.ru
What the charts say about Caribou Biosciences Inc. today2025 Price Targets & AI Enhanced Trading Signals - Newser
Using economic indicators to assess Caribou Biosciences Inc. potentialJuly 2025 Outlook & Weekly Setup with High ROI Potential - Newser
Is a relief rally coming for Caribou Biosciences Inc. holdersJuly 2025 Action & Weekly Breakout Watchlists - Newser
Will Breakout in Caribou Biosciences Inc. Sustain Through Next WeekPortfolio Update Report & AI Powered Buy/Sell Recommendations - beatles.ru
Caribou Biosciences Inc Stock (CRBU) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):